Changes in microRNAs expression are involved in age-related atrial structural remodeling and atrial fibrillation

Chinese Medical Journal

Volumn 126, Issue 8, 2013, Pages 1458-1463

  Xu, Guo jun ^a   Gan, Tian yi ^a   Tang, Bao peng ^a   Chen, Zu heng ^a   Mahemuti, Ailiman ^a   Zhou, Xian hui ^a   Jiang, Tao ^a   Song, Jian guo ^a   Guo, Xia ^a   Li, Yao dong ^a   Miao, Hai jun ^a   Zhang, Yu ^a   Li, Jin xin ^a  

^a XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

Aging; Atrial fibrillation; MicroRNAs; Structural remodeling

Indexed keywords

CEFAZOLIN; MICRORNA; MICRORNA 1; MICRORNA 133; MICRORNA 21; MICRORNA 29; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOG; DOWN REGULATION; ELECTROCARDIOGRAPHY; ELECTRON MICROSCOPY; GENE EXPRESSION; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HISTOPATHOLOGY; IN VITRO STUDY; MICROSCOPY; MUSCLE CELL; NICK END LABELING; NONHUMAN; PULSE GENERATOR; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; SINUS RHYTHM; THORACOTOMY; ULTRASTRUCTURE;

AGE FACTORS; ANIMALS; APOPTOSIS; ATRIAL FIBRILLATION; ATRIAL REMODELING; CONNECTIVE TISSUE GROWTH FACTOR; DOGS; ELECTROCARDIOGRAPHY; FIBROSIS; IN SITU NICK-END LABELING; MICRORNAS; MYOCARDIUM;

EID: 84876349085     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20121233     Document Type: Article

References (23)

1. Nattel S. New ideas about atrial fibrillation 50 years on. Nature 2002; 415: 219-226.
2. Dobrev D, Ravens U. Remodeling of cardiomyocyte ion channels in human atrial fibrillation. Basic Res Cardiol 2003; 98: 137-148.
3. Kostin S, Klein G, Szalay Z, Hein S, Bauer EP, Schaper J. Structural correlate of atrial fibrillation in human patients. Cardiovasc Res 2002; 54: 361-379.
4. Everett TH, Wilson EE, Verheule S, Guerra JM, Foreman S, Olgin J. Structural atrial remodeling alters the substrate and spatiotemporal organization of AF: a comparison in canine models of structural and electrical atrial remodeling. Am J Physiol Heart Circ Physiol 2006; 291: H2911-H2923.
5. Lockshin RA, Facey CO, Zakeri Z. Cell death in the heart. Cardiol Clin 2001; 19: 1-11.
6. Spinale FG. Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. Physiol Rev 2007; 87: 1285-342.
7. Bouzeghrane F, Reinhardt DP, Reudelhuber TL, Thibault G. Enhanced expression of fibrillin-1, a constituent of the myocardial extracellular matrix in fibrosis. Am J Physiol Heart Circ Physiol 2005; 289: H982-H991.
8. Boehm M, Slack F. A developmental timing microRNA and its target regulate life span in C. elegans. Science 2005; 310: 1954-1957.
9. Chen LH, Chiou GY, Chen YW, Li HY, Chiou SH. MicroRNA and aging: a novel modulator in regulating the aging network. Ageing Res Rev 2010; 9: S59-S66.
10. Grillari J, Grillari-Voglauer R. Novel modulators of senescence, aging, and longevity: small non-coding RNAs enter the stage. Exp Gerontol 2010; 45: 302-311.
11. Ikeda S, Kong SW, Lu J, Bisping E, Zhang H, Allen PD, et al. Altered microRNA expression in human heart disease. Physiol Genomics 2007; 31: 367-373.
12. Luo X, Xiao J, Lin H, Li B, Lu Y, Yang B, et al. Transcriptional activation by stimulating protein 1 and post-transcriptional repression by musclespecific microRNAs of IKs-encoding genes and potential implications in regional heterogeneity of their expressions. J Cell Physiol 2007; 212: 358-367.
13. Yang B, Lin H, Xiao J, Lu Y, Luo X, Li B, et al. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med 2007; 13: 486-491.
14. Boyle AJ, Shih H, Hwang J, Ye J, Lee B, Zhang Y, et al. Cardiomyopathy of aging in the mammalian heart is characterized by myocardial hypertrophy, fibrosis and a predisposition towards cardiomyocyte apoptosis and autophagy. Exp Gerontol 2011; 46: 549-559.
15. Xu C, Lu Y, Pan Z, Chu W, Luo X, Lin H, et al. The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes. J Cell Sci 2007; 120: 3045-3052.
16. Watanabe Y, Tomita M, Kanai A. Computational methods for microRNA target prediction. Methods Enzymol 2007; 427: 65-86.
17. Sayed D, Hong C, Chen IY, Lypowy J, Abdellatif M. MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ Res 2007; 100: 416-424.
18. Cheng YH, Ji RR, Yue JM, Yang J, Liu XJ, Chen H, et al. MicroRNAs are aberrantly expressed in hypertrophic heart - do they play a role in cardiac hypertrophy? Am J Pathol 2007; 170: 1831-1840.
19. Ji R, Cheng Y, Yue J, Yang J, Liu X, Chen H, et al. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. Circ Res 2007; 100: 1579-1588.
20. Shan H, Zhang Y, Lu Y, Zhang Y, Pan Z, Cai B, et al. Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines. Cardiovasc Res 2009; 83: 465-472.
21. Van Rooij E, Sutherland LB, Thatcher JE, DiMaio JM, Naseem RH, Marshall WS, et al. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci U S A 2008; 105: 13027-13032.
22. Thum T, Gross C, Fiedler J, Fischer T, Kissler S, Bussen M, et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 2008; 456: 980-984.
23. Van Rooij E, Sutherland LB, Liu N, Williams AH, McAnally J, Gerard RD, et al. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci U S A 2006; 103: 18255-18260.